Drug pricing transparency
Drug pricing transparency requirements are an unconventional pressure point for Energy, Power & Commodities firms, but employer health plan obligations under rules enforced by the U.S. Centers for Medicare & Medicaid Services and the U.S. Department of Labor have direct compliance teeth for any company sponsoring group health coverage at scale. The Consolidated Appropriations Act's machine-readable file mandates and broker compensation disclosure rules are not sector-carve-outs; energy conglomerates with large workforces are subject on the same terms as any other employer. Compliance teams at major utilities and commodity traders are currently auditing their third-party administrator contracts to confirm CAA-compliant price transparency file publication ahead of enforcement escalation.
Watch
- CMS machine-readable file enforcement: deadlines and penalty posture for large employer plans
- DOL broker/consultant compensation disclosure requirements under CAA Section 202
- Gag clause prohibition attestations: annual filing deadline for self-insured plan sponsors
- State-level drug pricing transparency boards encroaching on employer plan reporting in CA and CO
Recent material activity in Energy, Power & Commodities
Active monitoring in place across Energy, Power & Commodities. Material developments related to drug pricing transparency will appear here as they are published.